Semler Scientific (NASDAQ:SMLR – Get Free Report) announced its earnings results on Tuesday. The company reported $3.41 earnings per share for the quarter, topping analysts’ consensus estimates of $0.20 by $3.21, Zacks reports. The company had revenue of $12.41 million for the quarter. Semler Scientific had a return on equity of 50.77% and a net margin of 72.65%.
Semler Scientific Trading Up 3.0 %
Shares of SMLR opened at $52.22 on Thursday. Semler Scientific has a 12 month low of $20.88 and a 12 month high of $81.56. The firm’s 50 day moving average is $57.20 and its 200-day moving average is $42.51. The stock has a market capitalization of $484.08 million, a PE ratio of 10.64 and a beta of 1.17.
Wall Street Analyst Weigh In
Separately, Lake Street Capital lifted their target price on Semler Scientific from $40.00 to $71.00 and gave the stock a “buy” rating in a report on Friday, January 24th.
Semler Scientific Company Profile
Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition.
Featured Stories
- Five stocks we like better than Semler Scientific
- What is Put Option Volume?
- SoundHound AI Stock at a Crossroads—Is a Bottom in Sight?
- What is the Nikkei 225 index?
- Hershey’s Sweet Comeback: Why Investors Are Taking Notice
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- 3 Reasons Occidental Petroleum Will Gush Higher in 2025
Receive News & Ratings for Semler Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Semler Scientific and related companies with MarketBeat.com's FREE daily email newsletter.